Safety of Nerivio in Pregnant Women With Migraine

CompletedOBSERVATIONAL
Enrollment

145

Participants

Timeline

Start Date

August 1, 2022

Primary Completion Date

November 28, 2022

Study Completion Date

December 7, 2022

Conditions
MigrainePregnancy Related
Interventions
DEVICE

Nerivio

Nerivio is a Remote Electrical Neuromodulation (REN) device for the acute treatment of migraines. The device delivers transcutaneous electrical stimulation to the upper arm to induce conditioned pain modulation (CPM) that activates a descending endogenous analgesic mechanism. The treatment is self-administered and controlled by a smartphone application

DRUG

Migraine Relief

Any drug for treatment of migraine relief

Trial Locations (2)

92037

University of California San Diego (UCSD), San Diego

07042

Theranica USA, Montclair

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Theranica

INDUSTRY

NCT05464069 - Safety of Nerivio in Pregnant Women With Migraine | Biotech Hunter | Biotech Hunter